Cor Vasa 2025, 67(6):751-757

Neuregulin-1 and Cardiovascular Diseases

Lutfu Askina, Yahya Urkmezb, Hakan Ozerolc
a Department of Cardiology, Gaziantep Islamic Science and Technology University, Gaziantep, Turkey
b Department of Internal Medicine, Gaziantep City Hospital, Gaziantep, Turkey
c Department of Emergency Medicine, Gaziantep City Hospital, Gaziantep, Turkey

Cardiac tissue expresses neuregulin-1 (NRG-1), a growth factor. NRG-1 may treat heart failure (HF), myocardial infarction, cardiomyopathy, and arrhythmias. NRG-1 improves angiogenesis, cardiomyocyte development, and cardiac fibrosis in HF. These effects increase left ventricular function and minimise cardiac events (CE). NRG-1 reduces myocardial infarct size and promotes tissue regeneration. Angiogenesis and reduced inflammation and fibrosis in the infarcted region by NRG-1 minimise the incidence of unfavourable CE. NRG-1 improves left ventricular function and cardiac fibrosis in cardiomyopathy. NRG-1 modulates ion channels and reduces cardiac inflammation and fibrosis to lower arrhythmia risk. NRG-1 modulates ion channels and reduces cardiac inflammation and fibrosis in arrhythmias. NRG-1-based therapeutics for cardiovascular dis- eases (CVDs) are promising, but further research is required to maximise their usage. However, NRG-1 as a therapeutic target for CVDs is an exciting area of research that may lead to new and better treatments for these common and serious conditions.

Keywords: Cardiovascular diseases, Left ventricular function, Neuregulin-1

Received: February 21, 2025; Revised: February 21, 2025; Accepted: March 24, 2025; Prepublished online: June 2, 2012; Published: December 15, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Askin L, Urkmez Y, Ozerol H. Neuregulin-1 and Cardiovascular Diseases. Cor Vasa. 2025;67(6):751-757.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lin Y, Liu H, Wang X. Neuregulin-1, a microvascular endothelialderived protein, protects against myocardial ischemia-reperfusion injury (Review). Int J Mol Med 2020;46:925-935. Go to original source...
    2. Arora H, Lavin AC, Balkan W, et al. Neuregulin-1, in a conducive milieu with Wnt/BMP/retinoic acid, prolongs the epicardial-mediated cardiac regeneration capacity of neonatal heart explants. J Stem Cells Regen Med 2021;17:18-27. Go to original source...
    3. Kundumani-Sridharan V, Subramani J, Owens C, Das KC. Nrg-1β released in remote ischemic preconditioning improves myocardial perfusion and decreases ischemia/reperfusion injury via ErbB2-mediated rescue of endothelial nitric oxide synthase and abrogation of Trx2 autophagy. Arterioscler Thromb Vasc Biol 2021;418:2293-2314. Go to original source...
    4. Sun K, Li YY, Jin J. A double-edged sword of immunomicroenvironment in cardiac homeostasis and injury repair. Signal Transduct Target Ther 2021;6:79. Go to original source...
    5. Rupert C E, Coulombe KL. The roles of neuregulin-1 in cardiac development, homeostasis, and disease. Biomark Insights 2015;10:1-9. Go to original source...
    6. Chou CF, Ozaki M. In silico analysis of neuregulin 1 evolution in vertebrates. Biosci Rep 2010;30:267-275. Go to original source...
    7. Yin DM, Chen YJ, Liu S, et al. Calcyon stimulates neuregulin 1 maturation and signaling. Mol. Psychiatry 2015;20:1251-1260. Go to original source...
    8. Wang Y, Wei J, Zhang P, et al. Neuregulin-1, a potential therapeutic target for cardiac repair. Front Pharmacol 2022;13:945206. Go to original source...
    9. Lemmens K, Doggen K, De Keulenaer GW. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: Implications for therapy of heart failure. Circulation 200;116:954-960.
    10. Lemmens K, Fransen P, Sys SU, et al. Neuregulin-1 induces a negative inotropic effect in cardiac muscle: Role of nitric oxide synthase. Circulation 2004;109:324-326. Go to original source...
    11. Shakeri H, Gevaert AB, Schrijvers DM, et al. Neuregulin-1 attenuates stress-induced vascular senescence. Cardiovasc Res 2018;114:1041-1051. Go to original source...
    12. Ding Z, Dai C, Zhong L, et al. Neuregulin1 converts reactive astrocytes toward oligodendrocyte lineage cells via upregulating the PI3K-AKT-mTOR pathway to repair spinal cord injury. Biomed Pharmacother 2021;134:111168. Go to original source...
    13. Kataria H, Alizadeh A, Karimi-Abdolrezaee S. Neuregulin-1/ErbB network: An emerging modulator of nervous system injury and repair. Prog Neurobiol 2019;180:101643. Go to original source...
    14. Dugaucquier L, Feyen E, Mateiu L, et al. The role of endothelial autocrine NRG-1/ERBB4 signaling in cardiac remodeling. Am J Physiol Heart Circ Physiol 2020;319:443-455. Go to original source...
    15. D'Uva G, Aharonov A, Lauriola M, et al. ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation. Nat Cell Biol 2015;17:627-638. Go to original source...
    16. Dey A, Varelas X, Guan KL. Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov 2020;19:480-494. Go to original source...
    17. Zhang Y, Re DD. A growing role for the Hippo signaling pathway in the heart. J Mol Med 2017;95:465-472. Go to original source...
    18. Mahiny-Shahmohammady D, Hauck L, Billia F. Defining the molecular underpinnings controlling cardiomyocyte proliferation. Clin Sci 2022;136:911-934. Go to original source...
    19. Meng D, Pan H, Chen Y, et al. Roles and mechanisms of NRG-1 in modulating the pathogenesis of NAFLD through ErbB3 signaling in hepatocytes (NRG-1 modulates NAFLD through ErbB3 signaling). Obes Res Clin Pract 2021;15:145-151. Go to original source...
    20. Zhang J, Ji JY, Yu M, et al. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat Cell Biol 2009;11:1444-1450. Go to original source...
    21. Wang F, Wang H, Liu X, et al. Neuregulin-1 alleviate oxidative stress and mitigate inflammation by suppressing NOX4 and NLRP3/caspase-1 in myocardial ischaemia-reperfusion injury. J Cell Mol Med 2021;25:1783-1795. Go to original source...
    22. Shakeri H, Gevaert AB, Schrijvers DM, et al. Neuregulin-1 attenuates stress-induced vascular senescence. Cardiovasc Res 2018;114:1041-1051. Go to original source...
    23. Xu G, Watanabe T, Iso Y, et al. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis. Circ Res 2009;105:500-510. Go to original source...
    24. Clement CM, Thomas LK, Mou Y, et al. Neuregulin-1 attenuates neointimal formation following vascular injury and inhibits the proliferation of vascular smooth muscle cells. J Vasc Res 2007;44:303-312. Go to original source...
    25. Haller P M, Goncalves IF, Acar E, et al. Relationship between plasma Neuregulin-1 and cardiac function in patients with ST-elevation. Rev Cardiovasc Med 2022;23:63. Go to original source...
    26. Belmonte F, Das S, Sysa-Shah P, et al. ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity. Am J Physiol Heart Circ Physiol 2015;309:1271-1280. Go to original source...
    27. Wang F, Wang H, Liu X, et al. Neuregulin-1 alleviate oxidative stress and mitigate inflammation by suppressing NOX4 and NLRP3/caspase-1 in myocardial ischaemia-reperfusion injury. J Cell Mol Med 2021;25:1783-1795. Go to original source...
    28. Wu L, Walas S, Leung W, et al. Neuregulin1-β decreases IL-1β-induced neutrophil adhesion to human brain microvascular endothelial cells. Transl Stroke Res 2015;6:116-124. Go to original source...
    29. Szablewski L. Glucose transporters in healthy heart and in cardiac disease. Int. J. Cardiol 2017;230:70-75. Go to original source...
    30. Honkoop H, de Bakker DE, Aharonov A, et al. Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart. Elife 2019;8:e50163. Go to original source...
    31. Pentassuglia L, Heim P, Lebboukh S, et al. Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes. Am J Physiol Endocrinol Metab 2016;310:782-794. Go to original source...
    32. Hotham WE, Henson FMD. The use of large animals to facilitate the process of MSC going from laboratory to patient-'bench to bedside. Cell Biol Toxicol 2020;36:103-114. Go to original source...
    33. Hedhli N, Dobrucki LW, Kalinowski A, et al. Endothelial-derived neuregulin is an important mediator of ischaemia induced angiogenesis and arteriogenesis. Cardiovasc Res 2012;93:516-524. Go to original source...
    34. Steffens S, Van Linthout S, Sluijter JPG, et al. Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: Consensus document from the joint 2019 meeting of the ESC working groups of cellular biology of the heart and myocardial function. Cardiovasc Res 2020;116:1850-1862. Go to original source...
    35. Fang SJ, Li PY, Wang CM., et al. Inhibition of endoplasmic reticulum stress by neuregulin-1 protects against myocardial ischemia/reperfusion injury. Peptides 2017;88:196-207. Go to original source...
    36. Hong X, Oh N, Wang K, et al. Human endothelial colony-forming cells provide trophic support for pluripotent stem cell-derived cardiomyocytes via distinctively high expression of neuregulin-1. Angiogenesis 2021;24:327-344. Go to original source...
    37. Gupte M, Lal H, Ahmad F, et al. Chronic neuregulin-1β treatment mitigates the progression of postmyocardial infarction heart failure in the setting of type 1 diabetes mellitus by suppressing myocardial apoptosis, fibrosis, and key oxidant-producing enzymes. J Card Fail 2017;23:887-899. Go to original source...
    38. De Keulenaer GW, Feyen E, Dugaucquier L, et al. Mechanisms of the multitasking endothelial protein NRG-1 as a compensatory factor during chronic heart failure. Circ Heart Fail 2019;12:e006288. Go to original source...
    39. Zurek M, Johansson E, Palmer M, et al. Neuregulin-1 induces cardiac hypertrophy and impairs cardiac performance in post-myocardial infarction rats. Circulation 2020;142:1308-1311. Go to original source...
    40. Bian Y, Sun M, Silver M, et al. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins. Am J Physiol Heart Circ Physiol 2009;297:1974-1983. Go to original source...
    41. Haller PM, Gonçalves IF, Acar E, et al. Relationship between plasma Neuregulin-1 and cardiac function in patients with ST-elevation myocardial infarction. Rev Cardiovasc Med 2022;23:63. Go to original source...
    42. Chang T, Liu C, Yang H, et al. Fibrin-based cardiac patch containing neuregulin-1 for heart repair after myocardial infarction. Colloids Surf B Biointerfaces 2022;220:112936. Go to original source...
    43. Bossers GPL, Günthel M, van der Feen DE, et al. Neuregulin-1 enhances cell-cycle activity, delays cardiac fibrosis, and improves cardiac performance in rat pups with right ventricular pressure load. J Thorac Cardiovasc Surg 2022;164:493-510. Go to original source...
    44. Cui MY, Fu YQ, Li ZL, et al. Neuregulin-1/PI3K signaling effects on oligodendrocyte proliferation, remyelination and behaviors deficit in a male mouse model of ischemic stroke. Exp Neurol 2023;362:114323. Go to original source...
    45. Zhbanov KA, Shchendrygina AA, Salakheeva EY, et al. The Prognostic Value of Neuregulin-1β in Heart Failure Patients With Preserved Ejection Fraction. Kardiologiia 2022;62:3-8. Go to original source...
    46. Shakeri H, Boen JRA, De Moudt S, et al. Neuregulin-1 compensates for endothelial nitric oxide synthase deficiency. Am J Physiol Heart Circ Physiol 2021;320:2416-2428. Go to original source...
    47. Yamaguchi N, Xiao J, Narke D, et al. Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling. Circulation 2021;143:805-820. Go to original source...
    48. Wang JF, Li FH, Shen DL, et al. [Effect of neuregulin-1 on cardiac glucose metabolism in rats with experimental myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi 2021;49:912-919.
    49. Huang M, Zheng J, Chen Z, et al. The Relationship Between Circulating Neuregulin-1 and Coronary Collateral Circulation in Patients with Coronary Artery Disease. Int Heart J 2020;61:115-120. Go to original source...
    50. Wang X, Zhang F, Ma W, et al. Increased Levels of Serum Neuregulin 1 Associated with Cognitive Impairment in Vascular Dementia. Biomed Res Int 2020;2020:6683747. Go to original source...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content